World Pharma Newsfeed
Abbott reports double-digit ongoing earnings-per-share growth in fourth quarter and full-year 2011
Abbott's worldwide sales increased 4.1 percent to $10.4 billion, including a favorable 0.2 percent effect of foreign exc...
Novo Nordisk establishes type 1 diabetes R&D center in Seattle
Novo Nordisk will establish a type 1 diabetes R&D center in Seattle, US. The new center will combine Novo Nordisk's hist...
Roche supports cancer care development program in Ethiopia
Roche announced a grant to the Albert Einstein College of Medicine of Yeshiva University in New York City, which will be...
Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations
Increasingly, big pharma is viewing the outsourcing of pharmaceutical manufacturing as a strategic move that would enabl...
Sweeping genetic analysis of rare disease yields common mechanism of hypertension
Analyzing all the genes of dozens of people suffering from a rare form of hypertension, Yale University researchers have...
Genzyme and Veracyte Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients
Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY) and one of the world's leading biotechnology companies, and Vera...
'Pulverized' chromosomes linked to cancer?
They are the Robinson Crusoes of the intracellular world - lone chromosomes, whole and hardy, stranded outside the nucle...
Bristol-Myers Squibb Announces Charitable Donation of $6.9 Million to Support Cancer Patients
Bristol-Myers Squibb Company (NYSE: BMY) announced a donation of $6.9 million in 2011 to support the HealthWell Foundati...
Continuing uncertainties surround anti-influenza drug
Incomplete availability of data has hampered a thorough assessment of the evidence for using the anti-influenza drug ose...
Novartis receives approval for Lucentis® and launches Galvus® in China
Novartis received regulatory approval in China from the State Food and Drug Administration (SFDA) for Lucentis® (ranibiz...
